Apogee Therapeutics, Inc. APGE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$74.11M-33.9% | -$69.39M-3.2% | -$65.02M-32.6% | -$66.1M-95.5% | -$55.34M-72.4% | ||
| $408K+97.1% | $406K+434% | $400K+733% | $400K+1,011% | $207K+614% | ||
| $17.16M+54.2% | $11.93M+56.8% | $11.88M+103% | $11.34M+99.1% | $11.13M+166% | ||
| -$55.57M-14.6% | -$62.69M+7.4% | -$54.26M-27.6% | -$62.03M-112% | -$48.48M-53.2% | ||
| —— | $62K— | $0-100% | $768K+1,406% | $4.32M+1,130% | ||
| -$35.35M-372% | -$288.63M— | $17.95M+112% | $78.13M+153% | $12.98M+125% | ||
| $411.17M+66,004% | $374.95M+745% | $19.74M+5,054% | $1.18M— | $622K-99.9% | ||
| $320.25M+1,018% | —— | -$16.57M— | —— | -$34.87M-109% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Apogee Therapeutics, Inc. generate?
- Apogee Therapeutics, Inc. (APGE) generated -$234.5M in operating cash flow over the trailing twelve months.
- Where does Apogee Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Apogee Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.